TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸AARD

Aardvark Therapeutics, Inc. - Common Stock

NASDAQ
$0.92
▼ $2.98 (-76.3%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 20 Nov 2026
H $8.12L $0.90-79.8%
$8.12$6.68$5.23$3.79$2.34$0.9$0.92
RSI (14)
Intraday · 15-minSell-15RSI 43DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Sell-15
RSI (14)29
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$0.90
Resistance
$1.70
  • Price is below its 50-day average (medium-term weakness).
  • RSI is 29 — oversold, a level some traders read as a potential entry zone.

Signal backtest · 2026-02-20 → 2026-11-20

Strategy return
-3.7%
Buy & hold
-92.5%
Trades
2
Win rate
50%

$100,000.00 invested would be worth $96,348.10 (-3.7%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Aardvark Therapeutics, Inc.· Biotechnology

source: yahoo

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Employees
28
Headquarters
San Diego, United States
aardvarktherapeutics.com ↗

Fundamentals

No fundamental data is currently available for this listing from our data providers.

Recent news

News sentiment:▼ Negative0↑ · 1↓ · 7–
  • Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates— Neutral
    GlobeNewswire · 13 Nov 2026
  • Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?— Neutral
    Zacks · 05 Nov 2026
  • Raymond James Downgrades Aardvark Therapeutics to Market Perform— Neutral
    MT Newswires · 05 Nov 2026
  • HC Wainwright Adjusts PT on Aardvark Therapeutics to $2 From $4, Maintains Neutral Rating

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

— Neutral
MT Newswires · 26 Oct 2026
  • Sector Update: Healthcare Stocks Fall Late Afternoon▼ Negative
    MT Newswires · 23 Oct 2026
  • Top Midday Decliners— Neutral
    MT Newswires · 23 Oct 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.